2004Heilongjiang yiyao kexueRequires access

Serum level of the MMp-2 in ovarian malignant tumors

SU Ya-juan

Open publisher page 0 citations

Abstract

Objective: To explore the diagnostic value of serum MMp-2 level in the patients with ovarian carcinomas, and to evaluate the value between serum MMp-2 and metastasis and prognosis of ovarian cancer. Method: Serum MMp-2 level in patients with ovarian neoplasm(48 cases of ovarian carcinomas,24 of benign tumors) and 16 healthy women as controls was determined by enzyme linked immunosorbent assay(ELISA).Results: The preoperative serum MMp-2 level was (452.21±59.45)in the malignant group,and there was a significant difference compared with normal controls (89.34±33.83)or patients with benign tumor(197.78±45.27)(P0.05). Conclusion: Higher serum mmp-2 level in malignant tumors is important in tumor invasion and metastasis. Expression of MMp-2 in ovarian carcinomas appears to be well-characterized indicators of tumor prognosis and metastasis.

About this research paper

What this paper is about

Objective: To explore the diagnostic value of serum MMp-2 level in the patients with ovarian carcinomas, and to evaluate the value between serum MMp-2 and metastasis and prognosis of ovarian cancer. Method: Serum MMp-2 level in patients with ovarian neoplasm(48 cases of ovarian carcinomas,24 of benign tumors) and 16 healthy women as controls was determined by enzyme linked immunosorbent assay(ELISA).Results: The preoperative serum MMp-2 level was (452.21±59.45)in the malignant group,and there was a significant difference compared with normal controls (89.34±33.83)or patients with benign tumor(197.78±45.27)(P0.05). Conclusion: Higher serum mmp-2 level in malignant tumors is important in tumor invasion and metastasis. Expression of MMp-2 in ovarian carcinomas appears to be well-characterized indicators of tumor prognosis and metastasis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To explore the diagnostic value of serum MMp-2 level in the patients with ovarian carcinomas, and to evaluate the value between serum MMp-2 and metastasis and prognosis of ovarian cancer. Method: Serum MMp-2 level in patients with ovarian neoplasm(48 cases of ovarian carcinomas,24 of benign tumors) and 16 healthy women as controls was determined by enzyme linked immunosorbent assay(ELISA).Results: The preoperative serum MMp-2 level was (452.21±59.45)in the malignant group,and there was a significant difference compared with normal controls (89.34±33.83)or patients with benign tumor(197.78±45.27)(P0.05). Conclusion: Higher serum mmp-2 level in malignant tumors is important in tumor invasion and metastasis. Expression of MMp-2 in ovarian carcinomas appears to be well-characterized indicators of tumor prognosis and metastasis.

Key concepts: Medicine, Ovarian carcinomas, Metastasis, Ovarian cancer, Matrix metalloproteinase, Neoplasm, Internal medicine, Ovarian tumor

Related papers

Back to paper searchBrowse research topicsOriginal source
Serum level of the MMp-2 in ovarian malignant tumors — Research Paper | ScholarLens